Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Intellectual property investor IP Group said its portfolio company Oxford Nanopore Technologies had announced that it was in advanced development of an end-to-end test for the detection of the Covid-19 virus.
The LamPORE an end-to-end test (assay), based on Oxford Nanopore's DNA/RNA sequencing technology,was designed to cater to on-demand analysis of smaller sample numbers, to very large numbers of samples. LamPORE is
IP Group held an a stake of 16.4% in Oxford Nanopore.
At 8:33am: (LON:IPO) Ip Group PLC share price was +1.1p at 59p